Breaking News Instant updates and real-time market news.

BLK

BlackRock

$387.13

-6.4 (-1.63%)

, WETF

WisdomTree

$12.04

-0.16 (-1.31%)

12:17
12/22/16
12/22
12:17
12/22/16
12:17

Icahn says amount of money in ETFs is 'dangerous'

Carl Icahn, newly appointed adviser to President-elect Donald Trump, reiterated on CNBC his belief that the large amounts of money invested in exchanged traded funds is "dangerous." Shares of asset managers BlackRock (BLK), WisdomTree Investments (WETF), Legg Mason (LM) and Invesco (IVZ) are all lower in today's trading.

BLK

BlackRock

$387.13

-6.4 (-1.63%)

WETF

WisdomTree

$12.04

-0.16 (-1.31%)

LM

Legg Mason

$30.80

-0.57 (-1.82%)

IVZ

Invesco

$30.98

-0.46 (-1.46%)

BLK BlackRock
$387.13

-6.4 (-1.63%)

08/08/16
GSCO
08/08/16
DOWNGRADE
GSCO
Buy
BlackRock downgraded to Buy from Conviction Buy at Goldman
Goldman analyst Alexander Blostein removed BlackRock from the Conviction Buy List given expectations for a deceleration in near-term organic fee rate growth, which will limit multiple expansion. The analyst maintains his Buy rating and $400 price target saying BlackRock will deliver industry leading organic growth, but a more difficult mix shift could pressure the firm's overall fee rate/organic revenue growth.
10/14/16
DBAB
10/14/16
DOWNGRADE
Target $32
DBAB
Hold
Invesco downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Brian Bedell downgraded Invesco (IVZ) to Hold saying implementation of the Department of Labor rule in Q4 and Q1 will drive accelerating outflows in active mutual fund products. The analyst lowered his price target for the shares to $32 from $36. Bedell now favors BlackRock (BLK) in the Asset Managers space although he did lower his price target for the name to $416 from $418.
07/15/16
KBWI
07/15/16
DOWNGRADE
Target $383
KBWI
Market Perform
BlackRock downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Robert Lee downgraded BlackRock to Market Perform saying the company's "strong organic growth prospects" are largely priced into the shares at current levels. The analyst lowered his price target for the shares to $383 from $390 following BlackRock's Q2 results.
06/02/16
UBSW
06/02/16
UPGRADE
UBSW
Buy
Envestnet upgraded to Buy from Neutral at UBS
UBS analyst Brennan Hawken upgraded Envestnet to Buy saying the company is one of the few beneficiaries of the Department of Labor's fiduciary rule. Hawken this morning also downgraded Franklin Resources (BEN) to Sell and Invesco (IVZ) to Neutral. He also lowered his estimates for BlackRock (BLK) and T. Rowe Price (TROW).
WETF WisdomTree
$12.04

-0.16 (-1.31%)

12/16/16
BOFA
12/16/16
DOWNGRADE
Target $10
BOFA
Underperform
WisdomTree downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Michael Carrier downgraded WisdomTree to Underperform and lowered its price target to $10 from $11. The analyst expects increased competition to pressure flows and fees going forward and views valuation as "lofty."
11/29/16
JEFF
11/29/16
NO CHANGE
Target $12
JEFF
Buy
WisdomTree net flows on favorable trajectory, says Jefferies
Jefferies analyst Surinder Thind believes WisdomTree's net flows appear to be on a favorable trajectory after being positive in four of the previous five days. The stock looks positioned to outperform into year-end, Thind tells investors in a research note. He keeps a Buy rating on WisdomTree with a $12 price target.
11/02/16
UBSW
11/02/16
INITIATION
Target $7
UBSW
Sell
WisdomTree initiated with a Sell at UBS
UBS analyst Brennan Hawken started WisdomTree Investments with a Sell rating and $7 price target. The company is unlikely to benefit from the industry trend towards passive investing, Hawken tells investors in a research note. He notes that WisdomTree's flows have been "very poorly correlated" to the growth rates of exchange traded funds over the last few years.
10/31/16
SBSH
10/31/16
NO CHANGE
SBSH
Sell
WisdomTree removed from Focus List as a Sell at Citi
Citi analyst William Katz removed shares of WisdomTree from his firm's U.S. Focus List as a Sell. The analyst still sees downside in the stock, but feels it will "more of a grind" following the 8% post-earnings pullback. Katz keeps a Sell rating on WisdomTree.
LM Legg Mason
$30.80

-0.57 (-1.82%)

12/16/16
BOFA
12/16/16
DOWNGRADE
BOFA
Underperform
Legg Mason downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill analyst Michael Carrier downgraded Legg Mason two notches to Underperform and lowered its price target to $31 from $36. The analyst expects a rotation out of bonds and into equities to continue, slowing Legg Mason's organic growth and potentially absolute performance.
10/13/16
GABE
10/13/16
NO CHANGE
GABE
Buy
Legg Mason makes sense as target for Japanese investment, says Gabelli
Gabelli analyst Macrae Sykes noted that Legg Mason was mentioned yesterday in a report as a potential target for a strategic investment for a Japanese firm, which he believes would make sense as Japanese firms look to non-Japanese investments to improve returns. Legg Mason already has a 10% Asian investor in Shanda Group, notes Sykes, who tweaked his model slightly after Legg Mason reported AUM of $733B for the month of September. The analyst has a Buy rating on Legg Mason shares.
09/09/16
SBSH
09/09/16
NO CHANGE
Target $50
SBSH
Buy
Legg Mason EBITDA guidance points to Q3 upside, says Citi
Citi analyst William Katz believes the Q3 EBITDA guidance provided yesterday by Legg Mason points to earnings upside in the quarter. The analyst's math estimates the outlook translates to a 58c GAAP EPS mid-point equivalent, or 3c above consensus. The stock's non-reaction to the outlook presents a buying opportunity, Katz tells investors in a research note. He maintains a Buy rating on Legg Mason with a $50 price target.
07/18/16
WELS
07/18/16
NO CHANGE
WELS
Legg Mason shares could jump nearly 50%, says Wells Fargo
Wells Fargo believes that Legg Mason's stock could rally nearly 50%, driven largely by cost savings and share buybacks. The firm estimates that the company's EPS could jump about 50% in fiscal 2018. Wells calls Legg Mason "very inexpensive," and keeps an Outperform rating on the shares.
IVZ Invesco
$30.98

-0.46 (-1.46%)

06/27/16
SBSH
06/27/16
DOWNGRADE
Target $27
SBSH
Neutral
Invesco downgraded to Neutral from Buy at Citi
Citi analyst William Katz downgraded Invesco to Neutral saying the stock is likely "dead money" as investors contemplate the impacts from the Brexit vote. The analyst cut his price target for the shares to $27 from $38.
06/08/16
WELS
06/08/16
NO CHANGE
WELS
Invesco risk/reward ratio attractive, says Wells Fargo
Wells Fargo says that the 11% drop in Invesco's shares this year probably reflects macro issues rather than fundamentals. The firm thinks that the company has a number of potential positive catalysts in 2H16, including improving flows and stronger equity markets. It says that the company's relatively low valuation versus its peers "offers downside protection" going forward. Wells keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

SJB

ProShares Short High Yield

$23.28

0.0328 (0.14%)

06:46
11/21/17
11/21
06:46
11/21/17
06:46
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$78.90

-0.59 (-0.74%)

06:46
11/21/17
11/21
06:46
11/21/17
06:46
Earnings
Medtronic reports Q2 adjusted EPS $1.07, consensus 98c »

Reports Q2 revenue $7.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

BURL

Burlington Stores

$106.55

1.82 (1.74%)

06:45
11/21/17
11/21
06:45
11/21/17
06:45
Earnings
Burlington Stores reports Q3 adjusted EPS 70c, consensus 65c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.49

0.02 (0.02%)

06:45
11/21/17
11/21
06:45
11/21/17
06:45
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQD

iShares iBoxx $ Investment Grade Corporate Bond

06:45
11/21/17
11/21
06:45
11/21/17
06:45
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$157.78

1.23 (0.79%)

06:44
11/21/17
11/21
06:44
11/21/17
06:44
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLT

iShares 20+ Year Treasury Bond Fund

$126.34

-0.05 (-0.04%)

06:44
11/21/17
11/21
06:44
11/21/17
06:44
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRPT

Freshpet

$18.15

0.05 (0.28%)

06:44
11/21/17
11/21
06:44
11/21/17
06:44
Conference/Events
Freshpet management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

KIRK

Kirkland's

$12.82

0.29 (2.31%)

06:43
11/21/17
11/21
06:43
11/21/17
06:43
Earnings
Kirkland's sees FY17 EPS 50c-60c, consensus 60c »

Sees FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

DY

Dycom

$98.22

8.18 (9.08%)

06:43
11/21/17
11/21
06:43
11/21/17
06:43
Recommendations
Dycom analyst commentary  »

Dycom price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 28

    Nov

JEC

Jacobs Engineering

$59.34

0.71 (1.21%)

06:43
11/21/17
11/21
06:43
11/21/17
06:43
Hot Stocks
Breaking Hot Stocks news story on Jacobs Engineering »

Jacobs Engineering says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

JEC

Jacobs Engineering

$59.34

0.71 (1.21%)

06:42
11/21/17
11/21
06:42
11/21/17
06:42
Earnings
Breaking Earnings news story on Jacobs Engineering »

Jacobs Engineering sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

FSCT

ForeScout

$26.94

1.39 (5.44%)

06:42
11/21/17
11/21
06:42
11/21/17
06:42
Initiation
ForeScout initiated  »

ForeScout initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SLV

iShares Silver Trust

$15.98

-0.33 (-2.02%)

06:42
11/21/17
11/21
06:42
11/21/17
06:42
Technical Analysis
iShares Silver Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USLV

VelocityShares 3x Long Silver ETN

$11.72

-0.84 (-6.69%)

06:42
11/21/17
11/21
06:42
11/21/17
06:42
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$59.34

0.71 (1.21%)

06:41
11/21/17
11/21
06:41
11/21/17
06:41
Hot Stocks
Jacobs Engineering reports backlog of $19.8B at year end »

Up $1.2B vs. prior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PLNT

Planet Fitness

$30.15

0.07 (0.23%)

06:41
11/21/17
11/21
06:41
11/21/17
06:41
Initiation
Planet Fitness initiated  »

Planet Fitness initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$59.34

0.71 (1.21%)

06:40
11/21/17
11/21
06:40
11/21/17
06:40
Earnings
Jacobs Engineering reports Q4 adjusted EPS 98c, consensus 82c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

IYR

DJ US Real Estate Index Fund

$81.97

-0.17 (-0.21%)

06:40
11/21/17
11/21
06:40
11/21/17
06:40
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIRK

Kirkland's

$12.82

0.29 (2.31%)

06:40
11/21/17
11/21
06:40
11/21/17
06:40
Hot Stocks
Breaking Hot Stocks news story on Kirkland's »

Kirkland's reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

IBB

iShares Nasdaq Biotechnology Index

$308.33

-2.88 (-0.93%)

06:39
11/21/17
11/21
06:39
11/21/17
06:39
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIRK

Kirkland's

$12.82

0.29 (2.31%)

06:39
11/21/17
11/21
06:39
11/21/17
06:39
Earnings
Kirkland's reports Q3 EPS (15c), consensus (8c) »

Reports Q3 revenue $145M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

LABD

Daily S&P Biotech Bear 3x Shares

$5.51

0.11 (2.04%)

06:39
11/21/17
11/21
06:39
11/21/17
06:39
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$25.57

0.14 (0.55%)

06:38
11/21/17
11/21
06:38
11/21/17
06:38
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$32.73

0.02 (0.06%)

06:38
11/21/17
11/21
06:38
11/21/17
06:38
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.